Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Sad

<< Previous

Bullboard Posts

Next >>

Comment by nobeardon Aug 18, 2021 4:07pm

148 Views

Post# 33725005

RE:RE:RE:RE:RE:RE:RE:RE:RE:Sad

I was replying to your post regarding Tylenol, that you brought up,mentioning that the liver enzymes would never be that high when using the drug. I did not respond to the Tylenol and FDA statement. Google profilatics, and if they were as good back when as Tylenol should have been we would have been doublely blessed.

Rarbar99 wrote: Do you understand that it's a common fact that if Tylenol was invented today, it would not be approved, right? The FDA would reject it immediately and it would be tossed in the bin. Everyone knows this. Google it.

and yet you're trying to use this as an example? LOL just shows how delusional you are.

<< Previous

Bullboard Posts

Next >>

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles